Part 1: Executive Summary: 2015 Guidelines Update Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other
Robert W. Neumar University of Michigan NIH† None None None None None None
Dianne L. Atkins University of Iowa None None None None None None None
Farhan Bhanji McGill University None None None None None None None
Steven C. Brooks Queen’s University Heart and Stroke Foundation of Canada†; CIHR†; NIH† None None None None None South Eastern Ontario Academic Medical Association†
Clifton W. Callaway University of Pittsburgh None None None None None None None
Allan R. de Caen University of Alberta; Stollery Children’s Hospital None None None None None None None
Monica E. Kleinman Children’s Hospital Boston None None None None None None None
Steven L. Kronick University of Michigan None None None None None None None
Eric J. Lavonas Rocky Mountain Poison & Drug Center None None None None None None None
Mark S. Link Tufts Medical Center None None None None None None None
Mary E. Mancini University of Texas at Arlington None None None None None None None
Laurie J. Morrison University of Toronto NIH†; CIHR†; HSFC† None None None None None None
Robert E. O’Connor University of Virginia None None None None None None None
Eunice M. Singletary University of Virginia None None None None None American Red Cross Scientific Advisory Board* None
Myra H. Wyckoff UT Southwestern None None None None None None None
Staff
Jose Maria E. Ferrer American Heart Association None None None None None None None
Lana M. Gent American Heart Association None None None None None None None
Consultants
Michael W. Donnino Beth Israel Deaconess Med Center None None None None None American Heart Association† None
Mary Fran Hazinski Vanderbilt University None None None None None American Heart Association† None
Ricardo A. Samson University of Arizona None None None None None American Heart Association† None
Steven M. Schexnayder University of Arkansas; Arkansas Children’s Hospital None None None None None American Heart Association† None
Michael Shuster Mineral Springs Hospital Emergency Medicine None None None None None American Heart Association† None
Elizabeth H. Sinz Pennsylvania State University College of Medicine None None None None None American Heart Association† None
Andrew H. Travers Emergency Health Services, Nova Scotia None None None None None American Heart Association† None
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

†Significant.